Abstract
Of a total population of 305 million Americans, 58% are estimated to
experience insomnia symptoms or sleep disorders. Companies across America are
trying to sell us a perfect night' s sleep with pills, premium mattresses, high
tech pillows, white noise machines, aromatherapy, and more. And it has fast
become a $23.7 billion a year industry.
As obesity rates climb and Americans age, more people are developing sleep
apnea, restless legs syndrome and other sleep disorders. Plus, stressors from
the economy, terrorism and longer workdays is resulting in more sleepless
nights. Some claim that "sleep is the new sex-we need more of it and can' t get
enough of it." First launched in 1977, there are now 3,500 to 4,000 "sleep
labs" in the United States. These labs perform sleep studies and help design
treatment programs for insomniacs and those with sleep apnea and other
conditions.
This groundbreaking new Marketdata study examines the "sleep" market and its
components, covering markets for: anti-insomnia drugs (over-the-counter &
prescription), sleep labs/sleep centers, mattresses and pillows, CPAPs
(continuous positive airway pressure devices) for sleep apnea, and retail
sleep aids: earplugs, sleep lamps, sound conditioning machines, eye masks,
books on sleep). Marketdata also performed primary research -- a custom mail
survey of sleep labs in March-May, deriving key operating ratios, average
revenues, and much more.
The study includes market size estimates for 1987-2007, with 2008 and 2012
Forecasts, client demographics, in-depth competitor profiles and rankings in
each market segment, discussions of market nature & structure, history and
evolution, in view of recent Medicare rulings regarding home testing.
Advertising strategies, R&D, sleep disorder publicity and other demand factors
analyzed.
View Cart
